(R)-3-((1-methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide-D3; Relpax-D3; 3-[[(2R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole Hydrobromide-D3; Eletriptan Hydrobromide-D3; (R)-5-[2-(Benzenesulfonyl)ethyl]-3-[(N-methylpyrrolidin-2-yl)methyl]-1H-indole Hydrobromide-D3; Relert-D3; UK 116044-04-D3;
Eletriptan-d3 HBr is a fully characterized chemical compound used as a reference standard of API Eletriptan. The standard offered is compliant with regulatory guidelines. Eletriptan-d3 HBr is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 177834-92-3 (non-labelled)
